Menu
GeneBe

DCC

DCC netrin 1 receptor, the group of MicroRNA protein coding host genes|Fibronectin type III domain containing|I-set domain containing

Basic information

Region (hg38): 18:52340196-53535903

Links

ENSG00000187323NCBI:1630OMIM:120470HGNC:2701Uniprot:P43146AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mirror movements 1 (Definitive), mode of inheritance: AD
  • mirror movements 1 (Strong), mode of inheritance: AD
  • colorectal cancer (No Known Disease Relationship), mode of inheritance: Unknown
  • esophageal cancer (No Known Disease Relationship), mode of inheritance: Unknown
  • connective tissue disorder (Moderate), mode of inheritance: AR
  • gaze palsy, familial horizontal, with progressive scoliosis, 2 (Limited), mode of inheritance: AR
  • mirror movements 1 (Strong), mode of inheritance: AD
  • Kallmann syndrome (Supportive), mode of inheritance: AD
  • familial congenital mirror movements (Supportive), mode of inheritance: AD
  • mirror movements 1 and/or agenesis of the corpus callosum (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mirror movements 1; Gaze palsy, familial horizontal, with progressive scoliosis 2AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal; Neurologic19127048; 19720981; 20431009; 21242494; 28250456

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DCC gene.

  • not provided (84 variants)
  • Inborn genetic diseases (45 variants)
  • Mirror movements 1 (26 variants)
  • not specified (8 variants)
  • Gaze palsy, familial horizontal, with progressive scoliosis, 2 (8 variants)
  • - (4 variants)
  • DCC-related condition (3 variants)
  • Colorectal cancer (2 variants)
  • Mirror movements 1 and/or agenesis of the corpus callosum (2 variants)
  • Autism spectrum disorder (2 variants)
  • Malignant tumor of esophagus;Gaze palsy, familial horizontal, with progressive scoliosis, 2;Mirror movements 1;Colorectal cancer (2 variants)
  • Malignant tumor of esophagus;Colorectal cancer;Mirror movements 1;Gaze palsy, familial horizontal, with progressive scoliosis, 2 (1 variants)
  • Partial agenesis of the corpus callosum (1 variants)
  • Mirror movements 1;Colorectal cancer;Gaze palsy, familial horizontal, with progressive scoliosis, 2;Malignant tumor of esophagus (1 variants)
  • Bone marrow hypocellularity (1 variants)
  • Corpus callosum, agenesis of (1 variants)
  • Amenorrhea (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCC gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
13
clinvar
5
clinvar
19
missense
1
clinvar
76
clinvar
13
clinvar
4
clinvar
94
nonsense
5
clinvar
6
clinvar
11
start loss
1
clinvar
1
frameshift
5
clinvar
5
clinvar
10
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
1
clinvar
2
clinvar
7
splice region
3
2
3
8
non coding
1
clinvar
1
clinvar
4
clinvar
6
Total 14 14 81 27 13

Highest pathogenic variant AF is 0.00000657

Variants in DCC

This is a list of pathogenic ClinVar variants found in the DCC region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-52340789-T-C Partial agenesis of the corpus callosum Likely pathogenic (May 12, 2021)1077125
18-52340795-A-G DCC-related disorder Likely benign (Aug 31, 2020)3059262
18-52340813-GGGTACCCAAGCTGGCTTTTGTACTCTTCGGAGCTTCCTTGTTCAGCGCGCATCTTCAAGTAACCGGTAAGTGGCTCTTTCCTTTCTTCTCGTCGCACCCCCTTCCGTACCCCACTTCCCTTCTCATTTCATTTGGCGAGTAGTAGAATTGGGGTGGGGGATAGCAAGAGATTTGGCGCTTGCGCTGCCCCCATTTGCGCACCGATGATAAAAGATAGAAGAGTTTTTTTCTTCCCTGGGGGCGGATGATGGTGGGGGGGTGGTACAAGGGGCGCCCCTTCGCTGTTTTAAAATCTGATGCTTCACGCATTTTTGCTTCTGCAAATACTTGGGTTGGTTTGGAGAGCCGGCGGGCTGGGGCAGGTGCTGGGGATATCGTTGAAAGGAACTGGGCTGGGTCCTTAAAGCCCCAGAAACCTACCAAGTGGGGAGGATTGGGGCAACAGGAGCAGGCGAGGAGGACATCCAGGGGCTTTGAGGAAGTCTGCGCAGAATGTAGATGGTGGGGCTGAGTCGTTGGTGTGTGAATACATCTCCTTTTGGTTTGGATTTTTGGACTTGGTGATTGAGAATAGGGAAAGGGACAGCTAATATGTTTTGGTACTTCCAAGGAGGGGATCCTGGTACTGAAGGAGGCACAGAGTTGCCAAGGAGGAGGGGAGGTGTGTTTAATATTGTTTTATTTTTTAACGGTGAATGTAGTTCGCAAGCTGAGTCTCCATATAGCTCCAGGACACCTCCAAACTCCAAGTGATTGATATTCCAGAGAACCGGCGCCCTGACCCTGGCACTTGCCTAGCTCAGTTTCTAATTAAAAATGGCAAAACTGTTTGGGGATTGGATCTGGCTAGTGCAGGAGAAAGAGGGACCTGGAGGCTGGCTGATCAGGACTGCTGTAATCTCCGAATACGGAGCTGGCGGCTTCGACGGCCAAAAGAATAGAAAAGAGCAAAATGACTCATGATAAGGTCCACTTGTTTTGCGGGACCTCACCGCAAGTGTAGATGGGCACTGGGGTACAGTGAGCGGTCCTGGCAAAGAAGGAGAGGAGAGCGGCTGGATGAGCATTCAGAGAGCCCTTCGGAAACGACCTTTTTCCAAATCCAAAGGAAAAACAGGCTCAGGCAGAGACCGGGCGTTGAGTAGGAGCTCCCCAGTTCGTGCCTGGGAAATTAACAGGGAATGGCACATCAATCGCGGCCAAGCCCCCAGCCTCCCCGGAGTCCGCAGCTCCGGCTTTCTCTTCTCTGCTAAGTGCTGCATGGCCAAGGGTTGCGAACGCGAGCAGAAAATGCGCCTCTCACTGTCGCGAGGGATTCAGACAGTCAAGCGCCAAGGCAGCCCGAGGCTCCCCAAAGCCTCGCTCGGCCGCACGCGGGCAGGAATCTGCGCTTGCACTCGGGCTCAGCTCCTCATCTTCCTTTGGCCAGAGACAGAGAGAGCAGGCAGGAGGGGTGTGTGTGTGTGCGTGTGTGTGTGTGTGTGTGTGCACGCGCGCTGTCCTGTGATGAGCGCGTACCCGCATCCCCGCGCTTAGCCGCTGGTGCTCCCTCCCTCCGTCTGTCCCTCCCGGGCCGGTCCCCTCCTCCCCTGGCTCTTCTCTCCCGGAGCTTTGTCCTCAACAATTACTCTCGCAAAAGGTGGGTGGGGGTGGGGGGGTGGGCATCTCCACAGTAATGAATAGGTGTCTGTTTTAAATTGCCTCCTCGAGACCCTCAAATGCTAGAGGCTGCGGGGAGGAGGACCCTCCTTCTGCCCAGAAGATTGACTTGGGCTTTCTATAGCAGTTTGGGAGACCTATGCGGACGGGAAAGGGGAAGTTCAGGGGGCATCCCTTACTGGGTAGAAAGTCTGCCTAACAGCAGCACTGCTGACCTGAAATGTGCTAGCTGAATGCACTGCATGAAGCAAGGTGTACAAAAATGAACAATGATGTCTTGTCAATTACACGACAGTATTTTAAAGCTATTACTCAAGTGACTTTTGTCTGGCATAGGGTGGGGGTAGATTAATAGAGATAAATTTATGTGCGTTTTATTAATGTCTAAATTAATTAAATATTCTCTTTGCATTTATTTACATTTCTTGTCCAGAGAGTCAGGGCCATGTATTACTGCTTCATTTTAATTTTCTCCTCAACAGACAGATCTATGCTTGAAAAAGCAGATGTAAGGAAGGGATACATACACACACATACACATGGGTTATGTTGGTGGATAGGCTAACGGATCTAAATCTTTAAACTTTTCTGCACTTCTAAATCTATATCTGTTATTTGCAAGTGAGTCGTGATGCAGTTTGCGCAGCTCGCAGGAAAGTGGATGGTGCATTTTTAAGATATTGCCAATTCACAACACTCTGGCCTTTGCTCATTAATCTGAGTATCACTTCTTTCTCTTAGTAATAATTTCCCCTGTTTAGGAACATGGCAGGAAACTTACAACGAGAAAGCATAGTTCACTCTATAAAAGGACCAGTAGGAGGTGCCCTTAATAAGGCCAAGTGTCTAGTTTACTGGCAGAGAAATTCCCATTCAGCCGGGTGTTTTAAAGACTTTGTTGATTGGTAACAAAGGATTATGGAGACTAGCACAATAGCACTGGGCCCTTTCCCACTTTCTAGGTAAAGTCTGAAGCTGCTGTAGATTTGTATGAAACTGTGATGATTTAACAAAGGACAGCCCTGAAAAGTGTCAGTAGAGAGTGAGGACTTGATGTTGGGGGAGGAGGATGGTGACTTTTTAGTTGGCTTCTGTAAGATGTCATCTTCTTATATATTTGACATGAGCCACAGGCACAGGAACCTTATAGAGTCTCAGGGGATCTCAGATAAGATAACAATTTTGGATGTTGGATGTTAATGAGTGAAAAATGAGGCATACATATTAATTAATTCTTCATACATGTTTGGGTTCCATTGCATTGAAAAAAATCTGTGAGTGTTTAATGTAGTCTGGATATGCTGAAATGAGGCTGGTCGCCCTCCCTAGGCGACCTCTTCTCATTCCCCCAACCAAAGCAGATCAGATGCCCCCATGTGGGTTTGCTTTTGAGTGGCGGGAGTATGGCAGAGCCTGAGGGCTCGGGGTAGGCTGGCAGTCCACTCCTCTGTGAGTGCCGCAGTATAAATCACCAGTACCTGTCAGTGTCCATTTCCCACACAGCAGCAGCTGCCCTCTGAGTTATAAAGCATGGGAAACGGCCACCACATGTGTTATATGTGAATATATTAGGCTTAGTGCCTTTGCTTTAATGCTCTTAAAAGCCAGGCTGGCTTGAGATGCTGATAGGCATTTTTTTCTGGGGAGAGATTTATAACTTCTCAGTGTGTATGACTTAAATTTATTCTCTGGCAAGTTAACCTCTTAGCAAACTTCCTTATTGTTTTCATTGAAGAGGAAGAGCCTTAATCCTACCTAAATTCCTGAATGAAGCTCTGCTGAAAGTTTCTGCTAGAGTACAGGATATTTGCAGGCTGTAGTATGGTTTCCTAAACCAATGGGAAGCTTGACAAGATATATGGGGAGGTGATTTTTTGGTGGGGAGGCGGGGATATTTTTACTTGTTTTTAGAGAGGGAAGTTGTGATACTGCATCTTCTAAAGGAATTCTAGCAACTCAGTTATCTCAAAAGCATCTTTAATGAGAGGAAATGTTTCTCGCTTCCAGTTTCATACATCTAACAGTCTGGGATTCTTCAAATGCATATAATATGCTCCTGGAATGTTTGCAGCTGCACGCAGTAGGGTCATCTAGCAGGATCACTGTCATTTGGAAATGAGCCCTGATTTAAATTTTGACTTGCAGACAAAACACTTATCTTTACCTGGTGCGGCATGTTTAAAAGCAGTGCTGAAGTTTCTGAACAGAATATTTCTTTCCATGGGAGACTGTGCCCTAAGATTACATTTTAAAGTAAGTGTTCTTACCATTTCTTTGGAGAATTTGCCATCCCAAACTTTGCATGTGAAACTTCTTCTTCATGATTCTACCAGTAAAGATAACTATTTAAAGAGAATGCAGTTGTTTCCGGGTATTTCTTTAAAATTAAAATTCAATGTCCACATCCACACACAAACAAGGAGGATTTCCACCCCCTCATACCTTCTCCTTCAAATAGCTGACTTTGGTGTGAATTATGATAGCTCTAATTACATAAGGGCACTTGCAATTTCCCTAGAGAATGAGTTCTTGCCTGATTACAGATCTTCCTACTTTCCATAGGAAGTTTCTGGCCCACACTACTATCAGAAACTTGCACCAAATTGGGAACACATTGCTCTGTTTTGGTATTTGCTACCCAGCTATACATTTTTGAAGGATTAATCTACCTCAGATGATAATCTCTTAGATGAACTATATACATAAATTTCAAGAAATCTTAGCTTTGCCTGAGGCCAAAGAATAATGTCACAAACCTGCTGAAATTACTTGATTAATTGATTGATTAACTAAGGATAAAAAGTCACTTGGTTCTGGAAAAGTACTGTACTCCCTAAAGAGTTCTAAAGAGGAATAGTAAATACTATGCACATTTACAATTCATAAAATGTAAACGTCAAGTCTTCTTCCCCCTCTTTTTCCATTCCTTCCTTATAATGCTCTGGAGGAAAATTTAAGAGTTTCATGAGTTGTCACAACAGTTATATCTTAAGGAATCATAGCTTGGAATCTCACTAACTCATGATTAATAGACACTCAATTAAATAGCAACACAATGTCCGGTGAATTTTTCGGCAGCCTGCTGTGGGCTGCTTGCTTGTTTTCAGCTCGTTTCTAAGGAATCAAAACTCTCATCTCTAAGAGGTGTGGCATCAATACTGCCTCCCTTGACGCAGCCCAAGAAAGCCTTTCTCACTCTGAAACCAAGGCTGTGACCCACAGGCACTGTGTTTAATATGCTGTGTTCCACTTTGCAAGGTCAGGGGGATTTGCCTTAAAAATAAATTTTTAAATGTTCATGCATGCTGCTTTTGGTGGAGAGTTAAACTGTACTCTAAAAGCAGCTAAATAGTGTTGTTATCTTAAGACATTCTAACTTGTGGCCTCTCAGCCAATATTATTGAAGTTCTAGAGCTCACAATCTTTAAGAGAGACAGGAGTGAGCTCTATAAGATAATAGGTTATGCCAACCTAGTTAAGCTACTTTTTTCCCCAAAATGGTGTTACCAGGTTGGAATAATAGAACGTTAACCTTTTTCAAAGTTACTACTTTTCAGAGGAAAAAACATTTCTTAATAATATCATAATATCAGTAGCATGGGACTGACCCAATGTATTTAAGATATTGTTCTTCAAAACAAGATATCAAGGAAAGCCAGTGTTAAACTTGTCAAGAAGAAAGGATGAACAATCCAGATTATTTTCCCTGCAGGCCAATAAAAAATGTGCAAGATAGAATTACATGTTGCATATGCCAAATAGGTAATAGCAAAAAATAAAATGTAAAGTATTATGCACCTTTATCATTGCAGGACTCAGGTAAATGAAACACAATTTAGTAACACACTTTTTCTTTCTCTCACTCTAGAATGTTAATTCCTTATCTTATATTTCTCTGGTTTAACTCCAAACTAAGATGGAGAAATACAGGTTGGCTGACTGATGATCAAAATTATTATAGTGCTCCAAAGTTATTTGACAAATTTTAGCCTGAGGTTTAACAACTAAATCCCTTTAATTCAACTATTAAGTGAAAGTGTTTTCTTTGGTAGTTTAGAAATACCTGAGCTTTGTCCCAATGGTGTGGTTTAGAAATACATAATAATGCATAAGATTGAATATGCCTTCTTTTTCAATATTGATGGGAATTTGCCAATGGTAATACCAGTGCATATTGCTCTTTTATTAATAGTTCCAAACAACCATATTATTCACAGCTTTCATTTCTTGGGGGGAAAAGTTCAAGTAGGAAACACACAAATCATTCCATATTTATTGATCATATTTTTAAGGCTATTCTTATGGCATGACTTCTGTAGGAATGTTTCTCTTTTCTAGTAAATTCCACGAGCCCAGTGTCTATGATCTACTTCTACTTCGTGATATACTTTAGCTTAATTTCACTAATCCAAATTTTTTGACTTTTAGCTTGCTCAGTCATTTCACCATGGCCCTCCAGGGAGGAAGACCCTTTAAAACCATTTGTGGTTATGATGATGAAACTTAACAGGAGTATTTATTGCAATTTGGAGATTTCTTCCTGGTTCATCCTTTAAATATTGGTTCTTGCCTGAAGGCTACTCCTAAGAGTATCTAGGACAAACATGTTCCACTGAATTAACTGAATCTTTAGGATGTTATCTGATGAAAATACCAACTGGTTAGTGAATTGTGTTCTGATAAGAGGACTTGTCAATACAACATTATTCTGGGCCATCTACAATGTTCTTAAATCTGTGTTTACATTTTGACAAGAGAAAAAAGAAGTTAAGCAGTTAATATAAATGTTTTTAACTCAAATCACATTTTTAGATTTTACTTATTTTTCTATAGTCTTTTAGAAATATTTCTCCACTCACTTAGCTGCCTCTTTAAAAGTATGTAGAACATAATTTAACCTGTTCTTAATAGATACAATACATCACTATGACTTCATTATAGTATTATGTGATTTTATAGGGATAATTTTTGAAGGCATTGCATCATACAGAACTGTTTATTTTTCCCATCAATTGACCATGGACTGTTACTATTGTTGAGTTTTATCTCTGGCTATAAAATATATTTTGTCTACATCTTGTGTTCAGCTGAAACTTCTCCCTGTATAAAACTTCCTCAAAGCAGTTCTCTCTTTTAGTTTTGATGTTAAGACATAGGGGACTAAGTTTTGTTGGGGTTGTGTTTAAAGTAGGAGAGGAGATTAGAAAACAGCACCTGAATCCCTTATTAGAGGAATATCTAATTAGTTTTAACTAATGATTCTGTAGCATCTGATATTAATTTGGATGTCACTTGTACTTTGTACAACGTATTTTTCCTTATTAAATGAGAATGTGGACTAGATCAACTCTAGTTATTAGTTTCAACACTATATAATTTATTTAAATTATGAACTGTACTATACATATAGTGTTTGGTATAATTAATAATACAATTCATGATCATGATAACAATAATAATAATGTAATAATAACAAATACCCATGTACCCACTAGCAGTTTTCTGATTTTTGTATTAACCCCTTGCCTTTTGTACAGTTTTTCCACATATGTATACATCTTTAACATGTTACTTTACTTGGCTGTTCTTAACAGTAATAAAATAAATATAATGTGTATATTCTCTGACTTGCAATTTTGCTGAACGTTAAGTATCTGAGTTTCATCTATGTGGATTCATATTGCTGTATTTCAGTCACTTTCTCTGGTGTATAATACTTCATGATATTAATTAACCATAGTTTATCTAATCTATTGTTGATGGATTTTGAAATTCAGTTTTTTGCTATTGCTAGTAAAGTTGGCATAAACATTCTGGTGCATGTCCACCAGCACAAATTTGCCACCATGTTTAGGGTGCATACCTAGGAGTGGAATTGCTGAGTCATAGAAGGGTATCTTTTCATCCGGGAGGCAAAGACATGTTGCAGTTACTGAAACCCCCACCAGGGGCAGATGAAAGGCCTCTTTGCTTCATGCCTCTGCCAACACTTGGTATTTTCATATGCTTAATTTGCCCGCATCT-G Gaze palsy, familial horizontal, with progressive scoliosis, 2 Pathogenic (Apr 02, 2019)446759
18-52340836-C-G Inborn genetic diseases Uncertain significance (Sep 07, 2022)2311293
18-52340854-T-C Gaze palsy, familial horizontal, with progressive scoliosis, 2 • Mirror movements 1 Benign (Jul 30, 2021)1255454
18-52340885-G-A Mirror movements 1;Malignant tumor of esophagus;Gaze palsy, familial horizontal, with progressive scoliosis, 2;Colorectal cancer • DCC-related disorder Benign (Jul 21, 2021)709096
18-52752082-G-A Likely benign (Jan 01, 2023)2648721
18-52752125-G-C Uncertain significance (Apr 29, 2022)1305425
18-52752187-G-C Inborn genetic diseases Uncertain significance (Sep 06, 2022)2310734
18-52752212-G-A Inborn genetic diseases Uncertain significance (Sep 27, 2021)2386158
18-52752225-G-C Inborn genetic diseases Uncertain significance (Dec 06, 2022)2333224
18-52752265-C-T Benign (Dec 31, 2019)780478
18-52752316-G-A Gaze palsy, familial horizontal, with progressive scoliosis, 2 • Mirror movements 1 • DCC-related disorder Benign (Jul 30, 2021)1255455
18-52752333-C-T Colorectal cancer Uncertain significance (Jun 09, 2020)1030892
18-52752339-C-A Mirror movements 1 not provided (-)187794
18-52752346-T-A DCC-related disorder Likely benign (Aug 05, 2019)3035293
18-52906062-CACAG-C Likely pathogenic (Jul 13, 2022)2439657
18-52906070-G-A Inborn genetic diseases Uncertain significance (Feb 14, 2023)2483635
18-52906074-C-A Inborn genetic diseases Likely benign (Nov 07, 2023)3080407
18-52906134-T-C Esophageal carcinoma, somatic Pathogenic (Jun 01, 1994)17075
18-52906157-A-G Inborn genetic diseases Uncertain significance (Feb 25, 2022)2206998
18-52906158-A-G Mirror movements 1 not provided (-)187789
18-52906163-C-G Uncertain significance (Jun 14, 2022)1804232
18-52906180-C-T Likely benign (Jan 01, 2023)2648722
18-52906200-T-TG Mirror movements 1 Pathogenic (Apr 30, 2010)187795

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DCCprotein_codingprotein_codingENST00000442544 291191243
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9940.005521257200281257480.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3727527810.9630.00004359358
Missense in Polyphen179246.720.725522906
Synonymous-2.183352881.160.00001672959
Loss of Function6.831581.60.1840.00000530856

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001480.000148
Ashkenazi Jewish0.000.00
East Asian0.0002720.000217
Finnish0.00009240.0000924
European (Non-Finnish)0.0001320.000132
Middle Eastern0.0002720.000217
South Asian0.00009810.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for netrin required for axon guidance. Mediates axon attraction of neuronal growth cones in the developing nervous system upon ligand binding. Its association with UNC5 proteins may trigger signaling for axon repulsion. It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand. Implicated as a tumor suppressor gene. {ECO:0000269|PubMed:8187090, ECO:0000269|PubMed:8861902}.;
Disease
DISEASE: Mirror movements 1 (MRMV1) [MIM:157600]: A disorder characterized by contralateral involuntary movements that mirror voluntary ones. While mirror movements are occasionally found in young children, persistence beyond the age of 10 is abnormal. Mirror movements occur more commonly in the upper extremities. Some MRMV1 patients have agenesis of the corpus callosum. {ECO:0000269|PubMed:20431009, ECO:0000269|PubMed:28250454}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gaze palsy, familial horizontal, with progressive scoliosis, 2 (HGPPS2) [MIM:617542]: An autosomal recessive neurologic disorder characterized by global developmental delay, delayed walking, intellectual disability, horizontal gaze palsy, and childhood-onset progressive scoliosis. {ECO:0000269|PubMed:28250456}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Axon guidance - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Chromosomal and microsatellite instability in colorectal cancer;Developmental Biology;DSCAM interactions;Caspase activation via extrinsic apoptotic signalling pathway;Apoptosis;Programmed Cell Death;Regulation of commissural axon pathfinding by SLIT and ROBO;DCC mediated attractive signaling;Netrin mediated repulsion signals;Role of second messengers in netrin-1 signaling;Ligand-independent caspase activation via DCC;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance;Netrin-mediated signaling events (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.313
rvis_EVS
-1.36
rvis_percentile_EVS
4.52

Haploinsufficiency Scores

pHI
0.977
hipred
Y
hipred_score
0.736
ghis
0.532

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.762

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Dcc
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; neoplasm; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
dcc
Affected structure
efferent neuron
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
neuron migration;apoptotic process;axonogenesis;axon guidance;negative regulation of neuron projection development;spinal cord ventral commissure morphogenesis;dorsal/ventral axon guidance;anterior/posterior axon guidance;netrin-activated signaling pathway;negative regulation of collateral sprouting;extrinsic apoptotic signaling pathway in absence of ligand;postsynaptic modulation of chemical synaptic transmission;regulation of neuron death;negative regulation of netrin-activated signaling pathway;negative regulation of dendrite development
Cellular component
cytosol;plasma membrane;axon;Schaffer collateral - CA1 synapse;integral component of postsynaptic density membrane
Molecular function
transmembrane signaling receptor activity;netrin receptor activity;protein binding